Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection

被引:121
作者
Veronesi, U
Galimberti, V
Mariani, L
Gatti, G
Paganelli, G
Viale, G
Zurrida, S
Veronesi, P
Intra, M
Gennari, R
Vento, AR
Luini, A
Tullii, M
Bassani, G
Rotmensz, N
机构
[1] European Inst Oncol, Div Senol, I-20141 Milan, Italy
[2] European Inst Oncol, Div Epidemiol & Biostat, I-20141 Milan, Italy
[3] European Inst Oncol, Div Nucl Med, I-20141 Milan, Italy
[4] European Inst Oncol, Div Pathol, I-20141 Milan, Italy
[5] Univ Milan, I-20122 Milan, Italy
[6] European Inst Oncol, Div Anesthesiol, I-20141 Milan, Italy
关键词
negative sentinel node; follow-up; breast cancer; overt axillary metastases;
D O I
10.1016/j.ejca.2004.05.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sentinel node biopsy in patients with breast carcinoma accurately predicts the axillary nodal status. However, in some 6% of patients with negative sentinel nodes the remaining axillary nodes harbour metastases. Our purpose was to observe a large number of patients who did not undergo an axillary dissection after a negative sentinel node biopsy for the appearance of overt axillary metastases. 953 patients treated from 1996 to 2000, with negative sentinel nodes not submitted to axillary dissection, were followed-up to 7 years, with a median follow-up of 38 months. Fifty-five unfavourable events occurred among the 953 patients, 37 (4%) related to the primary breast carcinoma. Three cases of overt axillary metastases were found: they received total axillary dissection and are presently alive and well. The 5 year overall survival rate of the whole series was 98%. Patients with negative sentinel node biopsies not submitted to axillary dissection show during follow-up a rate of overt axillary metastases that is lower than that expected. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 27 条
[21]   Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series [J].
Veronesi, U ;
Paganelli, G ;
Viale, G ;
Galimberti, V ;
Luini, A ;
Zurrida, S ;
Robertson, C ;
Sacchini, V ;
Veronesi, P ;
Orvieto, E ;
De Cicco, C ;
Intra, M ;
Tosi, G ;
Scarpa, D .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (04) :368-373
[22]   Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes [J].
Veronesi, U ;
Paganelli, G ;
Galimberti, V ;
Viale, G ;
Zurrida, S ;
Bedoni, M ;
Costa, A ;
deCicco, C ;
Geraghty, JG ;
Luini, A ;
Sacchini, V ;
Veronesi, P .
LANCET, 1997, 349 (9069) :1864-1867
[23]   Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer [J].
Veronesi, U ;
Cascinelli, N ;
Mariani, L ;
Greco, M ;
Saccozzi, R ;
Luini, A ;
Aguilar, M ;
Marubini, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) :1227-1232
[24]  
VERONESI U, 1996, ONCOLOGIST, V1, P340
[25]  
Viale G, 1999, CANCER, V85, P2433, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2433::AID-CNCR18>3.0.CO
[26]  
2-3
[27]   Axillary radiotherapy instead of axillary dissection: A Randomized trial [J].
Zurrida, S ;
Orecchia, R ;
Galimberti, V ;
Luini, A ;
Giannetti, I ;
Ballardini, B ;
Amadori, A ;
Veronesi, G ;
Veronesi, U .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (02) :156-160